Engineers Gate Manager LP Esperion Therapeutics, Inc. Transaction History
Engineers Gate Manager LP
- $5.42 Billion
- Q4 2024
A detailed history of Engineers Gate Manager LP transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 53,373 shares of ESPR stock, worth $88,599. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,373
Previous 18,390
190.23%
Holding current value
$88,599
Previous $30,000
290.0%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ESPR
# of Institutions
215Shares Held
129MCall Options Held
1.78MPut Options Held
1.27M-
Wasatch Advisors Inc Salt Lake City, UT24.5MShares$40.6 Million0.27% of portfolio
-
Black Rock Inc. New York, NY14MShares$23.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$19.4 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V89.94MShares$16.5 Million0.44% of portfolio
-
Morgan Stanley New York, NY6.31MShares$10.5 Million0.0% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $110M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...